Ira Mellman
0000-0002-6132-7299
Publication & Citation Trends
Most Cited Works
Publications
457 total
Tricked by Edge Cases: Can Current Approaches Lead to Accurate Prediction of T-Cell Specificity with Machine Learning?
Cited by 0
Semantic Scholar
Tim-3-targeted vaccines overcome tumor immunosuppression and reduce cDC1 dependence to elicit potent anti-tumor immunity
Cited by 0
Semantic Scholar
A single MHCII neoepitope mRNA vaccine elicits CD4 T- and B- cell responses promoting endogenous CD8 anti-tumor immunity
Cited by 0
Semantic Scholar
Intratumoral heterogeneity and immunotherapy resistance: clinical implications.
Cited by 3
Semantic Scholar
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer
Cited by 2
Semantic Scholar
Recurrent RNA-lipoplex vaccination is required to sustain functional tumor-infiltrating neoantigen-specific CD8 T cells and therapeutic efficacy
Cited by 0
Semantic Scholar
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial OA
Cited by 66
Semantic Scholar
Abstract LB036: TIGIT blockade promotes intratumoral Treg cells with less suppressive and more effector-like phenotype to support antitumor responses
Cited by 0
Semantic Scholar
Research Topics
Immunotherapy and Immune Responses
(117)
Cancer Immunotherapy and Biomarkers
(97)
Cellular transport and secretion
(96)
Immune Cell Function and Interaction
(81)
T-cell and B-cell Immunology
(68)
Frequent Co-Authors
Affiliations
University of Geneva
Kansai Medical University
University of Vienna
The Royal Melbourne Hospital
Amgen (United States)